Gilead Sciences Long Term Deferred Charges (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

121.60 -1.14 (-0.93%) USD | NASDAQ | Jan 02, 16:00

121.30 -0.30 (-0.25%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Johnson & Johnson	--
Eli Lilly & Co.	--
Merck & Co., Inc.	--
Regeneron Pharmaceuticals, Inc.	--